COVID-19: Only updated medicines permitted for treatment

The Kerala High Court was informed by state government on Friday that it has taken a decision to only allow updated medicines for the treatment of novel coronavirus in the state.

The division bench of Justices Raja Vijayaraghavan and TR Ravi was hearing a petition seeking directions for the implementation of AYUSH notification and to permit homoeopathy to treat COVID-19 patients. The petitioner asked for more time to respond following which the High Court posted the matter for further hearing after summer vacation.

The bench told the petitioner that “The Supreme Court has already dismissed a petition which sought direction for permission of Homeopathy treatment for COVID-19. AYUSH Ministry has only suggested alternate medicine for boosting immunity and not as a treatment for COVID-19,” The petitioner said that the revised guidelines issued by the Union Ministry of Home Affairs have included the AYUSH system of medicine as activities permissible after April 20.

Kerala High Court had refused to issue any interim relief or directions on the matter.

The petitioner’s advocate MS Vineeth appearing party-in-person has sought directions to the state to refrain from acting coercively against homoeopathy practitioners treating COVID-19 patients.

  • Related Posts

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Dr Rajendra Pratap Gupta gets nominated to advise UN Secretary General Geneva/ New Delhi: Former advisor to Union Health Minister of India JP Nadda in his earlier stint and a…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

    Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

    Draft bill proposes powers for DIs to inspect online pharmacy office premises

    Draft bill proposes powers for DIs to inspect online pharmacy office premises

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

    FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

    FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

    Delhi DCA mandates digital tracking for controlled substances on new DMS portal

    Delhi DCA mandates digital tracking for controlled substances on new DMS portal

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?